Related Experiment Videos
[A study of 44 patients with Kirisawa type uveitis]
T Ichikawa1, J Sakai, Y Yamauchi
1Department of Ophthalmology, Tokyo Medical College, Japan.
Nippon Ganka Gakkai Zasshi
|March 1, 1997
Summary
Differentiating between varicella-zoster virus (VZV) and herpes simplex virus (HSV) is crucial for treating acute retinal necrosis, also known as Kirisawa-type uveitis (KU). Combined therapy shows effectiveness for VZV-KU, impacting visual prognosis.
Area of Science:
- Ophthalmology
- Virology
- Immunology
Context:
- Acute retinal necrosis, or Kirisawa-type uveitis (KU), is a severe ocular inflammatory condition.
- Viral pathogens, primarily varicella-zoster virus (VZV) and herpes simplex virus (HSV), are implicated in KU.
- Understanding the clinical spectrum and prognostic factors is essential for effective management.
Purpose:
- To investigate the clinical characteristics, viral etiology, disease grading, treatment strategies, and prognosis of KU.
- To compare the clinical presentations and outcomes between VZV-induced KU and HSV-induced KU.
- To identify factors influencing visual acuity and the efficacy of therapeutic interventions.
Summary:
- This study analyzed 50 eyes of 44 patients with KU, identifying VZV in 37 eyes and HSV in 13 eyes.
- VZV-KU cases were associated with older patients, more severe clinical signs (mutton fat keratic precipitates, retinal exudates), and a higher proportion of severe/serious grades compared to HSV-KU.
- Specific HLA antigen associations were noted in VZV-KU.
- Final visual acuity varied, with 32% of VZV-KU and 67% of HSV-KU eyes achieving >0.5 visual acuity.
- Combined therapy (acyclovir, interferon beta, prednisolone) demonstrated particular efficacy in improving visual outcomes for VZV-KU, but not significantly for HSV-KU.
Impact:
- Highlights the importance of identifying the specific viral cause (VZV vs. HSV) in KU for tailored treatment approaches.
- Suggests that early and specific therapeutic interventions, especially combination therapy for VZV-KU, can significantly improve visual prognosis.
- Provides insights into the distinct clinical and immunological profiles associated with different viral etiologies of KU.